An overview of chronic lymphocytic leukaemia biology

M. T S Bertilaccio, C. Scielzo, M. Muzio, F. Caligaris-Cappio

Research output: Contribution to journalArticle

Abstract

Chronic lymphocytic leukaemia (CLL) is characterised by accumulation of CD5+ monoclonal B cells in primary and secondary lymphoid tissues. Genetic defects and stimuli originating from the microenvironment concur to the selection and expansion of the malignant clone. Several lines of evidence, including molecular and functional analysis of the monoclonal immunoglobulin, support the hypothesis that stimulation through the B-cell receptor affects life and death of leukaemic cells. The microenvironment also has a critical role in the survival and accumulation of leukaemic cells within lymphoid organs where signals delivered from the surrounding cells are likely crucial in inducing proliferation. Nevertheless, several major biological issues still remain to be solved including regulation of the balance between proliferation and survival of leukaemic cells and the links between emerging gene abnormalities and microenvironment. In this context, mouse models are helpful tools in understanding disease mechanisms and in evaluating the efficacy of novel therapeutic agents.

Original languageEnglish
Pages (from-to)21-32
Number of pages12
JournalBest Practice and Research: Clinical Haematology
Volume23
Issue number1
DOIs
Publication statusPublished - Mar 2010

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
B-Lymphocytes
Cells
Lymphoid Tissue
Immunoglobulins
Cell Survival
Cell Death
Clone Cells
Lymphocytes
Functional analysis
Genes
Tissue
Therapeutics
Defects

Keywords

  • B-cell receptor
  • microenvironment
  • mouse models

ASJC Scopus subject areas

  • Oncology
  • Clinical Biochemistry

Cite this

An overview of chronic lymphocytic leukaemia biology. / Bertilaccio, M. T S; Scielzo, C.; Muzio, M.; Caligaris-Cappio, F.

In: Best Practice and Research: Clinical Haematology, Vol. 23, No. 1, 03.2010, p. 21-32.

Research output: Contribution to journalArticle

Bertilaccio, M. T S ; Scielzo, C. ; Muzio, M. ; Caligaris-Cappio, F. / An overview of chronic lymphocytic leukaemia biology. In: Best Practice and Research: Clinical Haematology. 2010 ; Vol. 23, No. 1. pp. 21-32.
@article{b498a8646ddb48a890e03a085d2cc14f,
title = "An overview of chronic lymphocytic leukaemia biology",
abstract = "Chronic lymphocytic leukaemia (CLL) is characterised by accumulation of CD5+ monoclonal B cells in primary and secondary lymphoid tissues. Genetic defects and stimuli originating from the microenvironment concur to the selection and expansion of the malignant clone. Several lines of evidence, including molecular and functional analysis of the monoclonal immunoglobulin, support the hypothesis that stimulation through the B-cell receptor affects life and death of leukaemic cells. The microenvironment also has a critical role in the survival and accumulation of leukaemic cells within lymphoid organs where signals delivered from the surrounding cells are likely crucial in inducing proliferation. Nevertheless, several major biological issues still remain to be solved including regulation of the balance between proliferation and survival of leukaemic cells and the links between emerging gene abnormalities and microenvironment. In this context, mouse models are helpful tools in understanding disease mechanisms and in evaluating the efficacy of novel therapeutic agents.",
keywords = "B-cell receptor, microenvironment, mouse models",
author = "Bertilaccio, {M. T S} and C. Scielzo and M. Muzio and F. Caligaris-Cappio",
year = "2010",
month = "3",
doi = "10.1016/j.beha.2009.12.005",
language = "English",
volume = "23",
pages = "21--32",
journal = "Best Practice and Research in Clinical Haematology",
issn = "1521-6926",
publisher = "Bailliere Tindall Ltd",
number = "1",

}

TY - JOUR

T1 - An overview of chronic lymphocytic leukaemia biology

AU - Bertilaccio, M. T S

AU - Scielzo, C.

AU - Muzio, M.

AU - Caligaris-Cappio, F.

PY - 2010/3

Y1 - 2010/3

N2 - Chronic lymphocytic leukaemia (CLL) is characterised by accumulation of CD5+ monoclonal B cells in primary and secondary lymphoid tissues. Genetic defects and stimuli originating from the microenvironment concur to the selection and expansion of the malignant clone. Several lines of evidence, including molecular and functional analysis of the monoclonal immunoglobulin, support the hypothesis that stimulation through the B-cell receptor affects life and death of leukaemic cells. The microenvironment also has a critical role in the survival and accumulation of leukaemic cells within lymphoid organs where signals delivered from the surrounding cells are likely crucial in inducing proliferation. Nevertheless, several major biological issues still remain to be solved including regulation of the balance between proliferation and survival of leukaemic cells and the links between emerging gene abnormalities and microenvironment. In this context, mouse models are helpful tools in understanding disease mechanisms and in evaluating the efficacy of novel therapeutic agents.

AB - Chronic lymphocytic leukaemia (CLL) is characterised by accumulation of CD5+ monoclonal B cells in primary and secondary lymphoid tissues. Genetic defects and stimuli originating from the microenvironment concur to the selection and expansion of the malignant clone. Several lines of evidence, including molecular and functional analysis of the monoclonal immunoglobulin, support the hypothesis that stimulation through the B-cell receptor affects life and death of leukaemic cells. The microenvironment also has a critical role in the survival and accumulation of leukaemic cells within lymphoid organs where signals delivered from the surrounding cells are likely crucial in inducing proliferation. Nevertheless, several major biological issues still remain to be solved including regulation of the balance between proliferation and survival of leukaemic cells and the links between emerging gene abnormalities and microenvironment. In this context, mouse models are helpful tools in understanding disease mechanisms and in evaluating the efficacy of novel therapeutic agents.

KW - B-cell receptor

KW - microenvironment

KW - mouse models

UR - http://www.scopus.com/inward/record.url?scp=77956643987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956643987&partnerID=8YFLogxK

U2 - 10.1016/j.beha.2009.12.005

DO - 10.1016/j.beha.2009.12.005

M3 - Article

C2 - 20620968

AN - SCOPUS:77956643987

VL - 23

SP - 21

EP - 32

JO - Best Practice and Research in Clinical Haematology

JF - Best Practice and Research in Clinical Haematology

SN - 1521-6926

IS - 1

ER -